Tag Archives: Favipiravir

Fujifilm Diosynth Biotechnologies Breaks Ground For Advanced Therapies Innovation Center in Texas

Fujifilm Diosynth Biotechnologies Breaks Ground For Advanced Therapies Innovation Center in Texas COLLEGE STATION, Texas, August 19, 2020 – FUJIFILM Diosynth Biotechnologies, a world leading contract development and manufacturing organization (CDMO) for biologics, viral vaccines and gene therapies, held a virtual ground-breaking ceremony on August 19, 2020 to signal the start of its Advanced Therapies […]

Posted in Press releases | Also tagged , , , | Leave a comment

FUJIFILM Diosynth Biotechnologies Expands Its Partnership With Novavax To Manufacture COVID-19 Vaccine Candidate At Its Billingham Site

FUJIFILM Diosynth Biotechnologies expands its partnership with Novavax to manufacture COVID-19 Vaccine Candidate at its Billingham site BILLINGHAM, UK, August 17,2020 — FUJIFILM Diosynth Biotechnologies, a world leading contract development and manufacturing organization (CDMO) for biologics, viral vaccines and gene therapies, announce today that its site in Billingham, UK will manufacture antigen component of NVX-CoV2373, […]

Posted in Press releases | Also tagged , , , | Leave a comment

Fujifilm Announces New SARS-CoV-2 RT-qPCR Detection Kit ver2

FUJIFILM Wako Junyaku Co., Ltd. (Head Office: Chuo-ku, Osaka, President: Kazuo Shiraki) is a pretreatment reagent for PCR testing, “SARS-CoV-2 Lysis Buffer,” which uses saliva as a sample and enables rapid testing for new coronaviruses. “, and the new coronavirus gene detection kit “SARS-CoV-2 RT-qPCR Detection Kit Ver2” will be released in Japan from July […]

Posted in Press releases | Also tagged , , , | Leave a comment

FUJIFILM Diosynth Biotechnologies Texas Facility to Support COVID-19 Vaccine Candidate Manufacturing

FUJIFILM Diosynth Biotechnologies Texas Facility to Support COVID-19 Vaccine Candidate Manufacturing COVID-19 vaccine manufacturing capacity reserved via a task order from BARDA College Station, Texas, July 27, 2020 — FUJIFILM Diosynth Biotechnologies, a world leading contract development and manufacturing organization (CDMO) for biologics, viral vaccines and gene therapies, announced today that its College Station, Texas, […]

Posted in Press releases | Also tagged , , , | Leave a comment

Fujifilm Partners With Dr. Reddy’s And Global Response Aid For Deployment Of A COVID-19 Treatment Drug Outside Of Japan

Fujifilm partners with Dr. Reddy’s and Global Response Aid for deployment of a COVID-19 treatment drug outside of Japan Licensing agreement was signed on the development, manufacture and sales of anti-influenza virus drug Avigan® Tablets. TOKYO, July 1, 2020 — FUJIFILM Corporation (President: Kenji Sukeno) partners with Dr. Reddy’s Laboratories Ltd. (Co-Chairman & Managing Director: G. […]

Posted in Press releases | Also tagged , , , | Leave a comment

Fujifilm Wako Introduces Line of Endotoxin Detection Reagents to U.S. Market

FUJIFILM Wako Introduces Line of Endotoxin Detection Reagents to U.S. Market PYROSTAR™ ES-F line for endotoxin detection poised to support quality assurance process of future COVID-19 vaccine manufacturing Richmond, Virginia, June 25, 2020 – FUJIFILM Wako Chemicals U.S.A. Corporation (FUJIFILM Wako), a wholly owned subsidiary of FUJIFILM Wako Pure Chemical Corporation of Japan, announced the U.S. introduction of the PYROSTAR™ ES-F line of limulus amebocyte lysate (LAL) reagents, which are engineered to detect the presence of bacterial endotoxins. The detection […]

Posted in Press releases | Also tagged , , , | Leave a comment